This is a study to evaluate the safety and effectiveness of Xyrem compared to placebo for the treatment of fibromyalgia. This national study is currently recruiting patients.
Read moreJazz Pharmaceuticals, Inc. announced it has submitted a New Drug Application to the FDA for JZP-6 (sodium oxybate oral solution) for the... Read more »
Last Friday, members of the FDA's Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee overwhelmingly... Read more »
Jazz Pharmaceuticals, Inc. has announced that the FDA's Arthritis Advisory Committee and Drug Safety and Risk Management Advisory Committee... Read more »
A little over a month ago, I told you that an FDA panel had recommended not approving sodium oxybate for fibromyalgia. On October 11, the... Read more »
Today, May 12, 2011 is National Fibromyalgia Awareness Day. As many of our users live with both RA and fibromyalgia, Karen Lee Richards -... Read more »
Experts with the U.S. Food and Drug Administration (FDA) have rejected the drug Xyrem (sodium oxybate) as a treatment for fibromyalgia, saying the... Read more »
Source: ADAM Encyclopedia
Fibromyositis; Fibrositis Prevention There is no known prevention. References Abeles M, Solitar BM, Pillinger MH, Abeles AM.... Read more »
Source: ADAM Encyclopedia
Fibromyositis; Fibrositis Symptoms Pain in the main symptom of fibromyalgia. It may be mild to severe. Painful areas are called... Read more »
Source: ADAM Encyclopedia
Fibromyositis; Fibrositis Treatment The goal of treatment is to help relieve pain and other symptoms, and to help a person cope with the... Read more »
Source: ADAM Encyclopedia
Fibromyalgia is a common syndrome in which a person has long-term, body-wide pain and tenderness in the joints, muscles, tendons, and other soft... Read more »